The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Webb, A. K. (2006) · Cited by 4,369
Methods for the economic evaluation of health care programmes
Wilson, S. H. (1987) · Journal of Epidemiology and Community Health · doi:10.1136/jech.41.4.355-a · Cited by 4,275
Antibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225
Charbonneau, D. H. (2005) · Europe PMC (PubMed Central) · Cited by 2,041
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Flume, P. A., O'Sullivan, B. P., Robinson, K. A., Goss, C. H., Mogayzel, P. J., Willey-Courand, D. B., Bujan, J., Finder, J., Lester, M., Quittell, L., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-664oc · Cited by 1,024
Self-citationEmerson, J., Rosenfeld, M., McNamara, S., Ramsey, B., & Gibson, R. L. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10127 · Cited by 1,007
The Changing Microbial Epidemiology in Cystic Fibrosis
LiPuma, J. J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00068-09 · Cited by 806
Cystic Fibrosis Pulmonary Guidelines: Treatment of Pulmonary Exacerbations
Flume, P. A., Mogayzel, P. J., Robinson, K. A., Goss, C. H., Rosenblatt, R. L., Kuhn, R. J., Marshall, B. C., & and the Clinical Practice Guidelines for Pulmonary Therapies Committee (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1845pp · Cited by 738
Self-citationLee, T. W. R., Brownlee, K. G., Conway, S. P., Denton, M., & Littlewood, J. M. (2003) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(02)00141-8 · Cited by 713
The Challenge of Treating Biofilm-associated Bacterial Infections
del Pozo, J. L., & Patel, R. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100247 · Cited by 671
Pseudomonas Aeruginosa Biofilms in Cystic fibrosis
H⊘iby, N., Ciofu, O., & Bjarnsholt, T. (2010) · Future Microbiology · doi:10.2217/fmb.10.125 · Cited by 666
Mulcahy, L. R., Burns, J. L., Lory, S., & Lewis, K. (2010) · Journal of Bacteriology · doi:10.1128/jb.01651-09 · Cited by 631
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
Döring, G., Conway, S. P., Heijerman, H. G. M., Hodson, M. E., Høiby, N., Smyth, A., Touw, D. J., & the Consensus Committee, F. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16d30.x · Cited by 620
Self-citationDecade-long bacterial community dynamics in cystic fibrosis airways
Zhao, J., Schloss, P. D., Kalikin, L. M., Carmody, L. A., Foster, B. K., Petrosino, J. F., Cavalcoli, J. D., VanDevanter, D. R., Murray, S., Li, J. Z., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120577109 · Cited by 599
Longitudinal Assessment of Pseudomonas aeruginosa in Young Children with Cystic Fibrosis
Burns, J. L., Gibson, R. L., McNamara, S., Yim, D., Emerson, J., Rosenfeld, M., Hiatt, P., McCoy, K., Castile, R., Smith, A. L., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/318075 · Cited by 555
Comparative Effectiveness Research: A Report From the Institute of Medicine
Sox, H. C., & Greenfield, S. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-3-200908040-00125 · Cited by 525
Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation
Sanders, D. B., Bittner, R. C. L., Rosenfeld, M., Hoffman, L. R., Redding, G. J., & Goss, C. H. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1421oc · Cited by 519
Pamp, S. J., Gjermansen, M., Johansen, H. K., & Tolker‐Nielsen, T. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06152.x · Cited by 486
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment
Valerius, N. H., Koch, C., & Høiby, N. (1991) · The Lancet · doi:10.1016/0140-6736(91)91446-2 · Cited by 475
Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis
Tunney, M. M., Field, T. R., Moriarty, T. F., Patrick, S., Doering, G., Muhlebach, M. S., Wolfgang, M. C., Boucher, R., Gilpin, D. F., McDowell, A., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1151oc · Cited by 468
Self-citationAirway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients
Cox, M. J., Allgaier, M., Taylor, B., Baek, M. S., Huang, Y. J., Daly, R. A., Karaoz, U., Andersen, G. L., Brown, R., Fujimura, K. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011044 · Cited by 451
Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa
Tateda, K., Comte, R., Péchère, J.-C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1930-1933.2001 · Cited by 401
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis*
Rosenfeld, M., Gibson, R. L., McNamara, S., Emerson, J., Burns, J. L., Castile, R., Hiatt, P., McCoy, K., Wilson, C. B., Inglis, A., et al. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.1144 · Cited by 395
Evolutionary dynamics of bacteria in a human host environment
Yang, L., Jelsbak, L., Marvig, R. L., Damkiær, S., Workman, C. T., Rau, M. H., Hansen, S. K., Folkesson, A., Johansen, H. K., Ciofu, O., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018249108 · Cited by 369
Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis
McCoy, K. S., Quittner, A. L., Oermann, C. M., Gibson, R. L., Retsch-Bogart, G. Z., & Montgomery, A. B. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1804oc · Cited by 356
Dasenbrook, E. C. (2010) · JAMA · doi:10.1001/jama.2010.791 · Cited by 353
Fodor, A. A., Klem, E. R., Gilpin, D. F., Elborn, J. S., Boucher, R. C., Tunney, M. M., & Wolfgang, M. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045001 · Cited by 353
Self-citationMeers, P., Neville, M., Malinin, V., Scotto, A. W., Sardaryan, G., Kurumunda, R., Mackinson, C., James, G., Fisher, S., & Perkins, W. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn059 · Cited by 345
Persistent Methicillin-resistant Staphylococcus aureus and Rate of FEV 1 Decline in Cystic Fibrosis
Dasenbrook, E. C., Merlo, C. A., Diener-West, M., Lechtzin, N., & Boyle, M. P. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200802-327oc · Cited by 319
Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis
Gibson, R. L., Emerson, J., McNamara, S., Burns, J. L., Rosenfeld, M., Yunker, A., Hamblett, N., Accurso, F., Dovey, M., Hiatt, P., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-855oc · Cited by 318
Rogers, G. B., Carroll, M. P., Serisier, D. J., Hockey, P. M., Jones, G., & Bruce, K. D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5176-5183.2004 · Cited by 318
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection
Renna, M., Schaffner, C., Brown, K., Shang, S., Tamayo, M. H., Hegyi, K., Grimsey, N. J., Cusens, D., Coulter, S., Cooper, J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46095 · Cited by 314
Konstan, M. W., Flume, P. A., Kappler, M., Chiron, R., Higgins, M., Brockhaus, F., Zhang, J., Angyalosi, G., He, E., & Geller, D. E. (2011) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2010.10.003 · Cited by 314
Self-citationComing together: the ATS/ERS consensus on clinical pulmonary function testing
Brusasco, V., Crapo, R., & Viegi, G. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034205 · Cited by 313
Sibley, C. D., Parkins, M. D., Rabin, H. R., Duan, K., Norgaard, J. C., & Surette, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804326105 · Cited by 312
Smith, A. L., Fiel, S. B., Mayer-Hamblett, N., Ramsey, B., & Burns, J. L. (2003) · Chest · doi:10.1378/chest.123.5.1495 · Cited by 307
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus
Döring, G., & Hoiby, N. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.03.008 · Cited by 304
Self-citationBarriers to Treatment Adherence for Children with Cystic Fibrosis and Asthma: What Gets in the Way?
Modi, A. C., & Quittner, A. L. (2006) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsj096 · Cited by 301
Ratjen, F., Munck, A., Kho, P., Angyalosi, G., & for the ELITE Study Group (2010) · Thorax · doi:10.1136/thx.2009.121657 · Cited by 291
Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
Retsch-Bogart, G. Z., Quittner, A. L., Gibson, R. L., Oermann, C. M., McCoy, K. S., Montgomery, A. B., & Cooper, P. J. (2009) · Chest · doi:10.1378/chest.08-1421 · Cited by 281
Allergic bronchopulmonary aspergillosis in cystic fibrosis
Laufer, P., Fink, J. N., Bruns, W. T., Unger, G. F., Kalbfleisch, J. H., Greenberger, P. A., & Patterson, R. (1984) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(84)90482-2 · Cited by 278
Heijerman, H., Westerman, E., Conway, S., & Touw, D. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.04.005 · Cited by 264
Self-citationRegelmann, W. E., Elliott, G. R., Warwick, W. J., & Clawson, C. C. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.4_pt_1.914 · Cited by 262
Sibley, C. D., Duan, K., Fischer, C., Parkins, M. D., Storey, D. G., Rabin, H. R., & Surette, M. G. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000184 · Cited by 261
Bjarnsholt, T., Jensen, P. Ø., Jakobsen, T. H., Phipps, R., Nielsen, A. K., Rybtke, M. T., Tolker-Nielsen, T., Givskov, M., Høiby, N., Ciofu, O., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010115 · Cited by 261
Eradication of early Pseudomonas aeruginosa infection
Høiby, N., Frederiksen, B., & Pressler, T. (2005) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2005.05.018 · Cited by 255
Longitudinal association between medication adherence and lung health in people with cystic fibrosis
Eakin, M. N., Bilderback, A., Boyle, M. P., Mogayzel, P. J., & Riekert, K. A. (2011) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2011.03.005 · Cited by 246
Pulmonary exacerbations in cystic fibrosis
Rabin, H. R., Butler, S. M., Wohl, M. E. B., Geller, D. E., Colin, A. A., Schidlow, D. V., Johnson, C. A., Konstan, M. W., & Regelmann, W. E. (2004) · Pediatric Pulmonology · doi:10.1002/ppul.20023 · Cited by 245
Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study
Mastella, G., Rainisio, M., Harms, H. K., Hodson, M. E., Koch, C., Navarro, J., Strandvik, B., McKenzie, S. G., & the investigators of the Epidemiologic Registry of Cystic Fibrosis, O. B. O. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.016003464.x · Cited by 244
Pseudomonas aeruginosa Population Diversity and Turnover in Cystic Fibrosis Chronic Infections
Mowat, E., Paterson, S., Fothergill, J. L., Wright, E. A., Ledson, M. J., Walshaw, M. J., Brockhurst, M. A., & Winstanley, C. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201009-1430oc · Cited by 241
Aaron, S. D., Vandemheen, K. L., Ferris, W., Fergusson, D., Tullis, E., Haase, D., Berthiaume, Y., Brown, N., Wilcox, P., Yozghatlian, V., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67060-2 · Cited by 240
Rogers, G. B., Hart, C. A., Mason, J. R., Hughes, M., Walshaw, M. J., & Bruce, K. D. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3548-3558.2003 · Cited by 223
Sagel, S. D., Gibson, R. L., Emerson, J., McNamara, S., Burns, J. L., Wagener, J. S., & Ramsey, B. W. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.08.001 · Cited by 219
Herrmann, G., Yang, L., Wu, H., Song, Z., Wang, H., Høiby, N., Ulrich, M., Molin, S., Riethmüller, J., & Döring, G. (2010) · The Journal of Infectious Diseases · doi:10.1086/656788 · Cited by 219
Self-citationRatjen, F., Döring, G., & Nikolaizik, W. H. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06124-4 · Cited by 218
Self-citationKlepac‐Ceraj, V., Lemon, K. P., Martin, T. R., Allgaier, M., Kembel, S. W., Knapp, A. A., Lory, S., Brodie, E. L., Lynch, S. V., Bohannan, B. J. M., et al. (2010) · Environmental Microbiology · doi:10.1111/j.1462-2920.2010.02173.x · Cited by 218
Review: Staphylococcus aureus and MRSA in cystic fibrosis
Goss, C. H., & Muhlebach, M. S. (2011) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2011.06.002 · Cited by 216
Treggiari, M. M., Retsch-Bogart, G., Mayer-Hamblett, N., Khan, U., Kulich, M., Kronmal, R., Williams, J., Hiatt, P., Gibson, R. L., Spencer, T., et al. (2011) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2011.136 · Cited by 215
Hansen, C. R., Pressler, T., & Høiby, N. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.06.009 · Cited by 214
Hansen, S. K., Rau, M. H., Johansen, H. K., Ciofu, O., Jelsbak, L., Yang, L., Folkesson, A., Jarmer, H. Ø., Aanæs, K., von Buchwald, C., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2011.83 · Cited by 213
Schuster, A., Haliburn, C., Döring, G., Goldman, M. H., & for the Freedom Study Group (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202059 · Cited by 208
Self-citationNontuberculous Mycobacteria: II: Nested-Cohort Study of Impact on Cystic Fibrosis Lung Disease
Olivier, K. N., Weber, D. J., Lee, J.-H., Handler, A., Tudor, G., Molina, P. L., Tomashefski, J., & Knowles, M. R. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-679oc · Cited by 201
Ciofu, O., Mandsberg, L. F., Bjarnsholt, T., Wassermann, T., & Høiby, N. (2010) · Microbiology · doi:10.1099/mic.0.033993-0 · Cited by 201
Wiesemann, H. G., Steinkamp, G., Ratjen, F., Bauernfeind, A., Przyklenk, B., Döring, G., & von der Hardt, H. (1998) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199802)25:2<88::aid-ppul3>3.0.co;2-j · Cited by 200
Self-citationAllergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
Geller, D. E., Kaplowitz, H., Light, M. J., & Colin, A. A. (1999) · Chest · doi:10.1378/chest.116.3.639 · Cited by 198
Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety
Geller, D. E., Konstan, M. W., Smith, J., Noonberg, S. B., & Conrad, C. (2007) · Pediatric Pulmonology · doi:10.1002/ppul.20594 · Cited by 196
Oermann, C. M., Retsch‐Bogart, G. Z., Quittner, A. L., Gibson, R. L., McCoy, K. S., Montgomery, A. B., & Cooper, P. J. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21301 · Cited by 187
Inflammatory Responses to Individual Microorganisms in the Lungs of Children With Cystic Fibrosis
Gangell, C., Gard, S., Douglas, T., Park, J., de Klerk, N., Keil, T., Brennan, S., Ranganathan, S., Robins-Browne, R., Sly, P. D., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir399 · Cited by 187
Döring, G., Meisner, C., Stern, M., & for the Flagella Vaccine Trial Study Group (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702403104 · Cited by 186
Self-citationFoweraker, J. E. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki146 · Cited by 184
Taylor-Robinson, D., Whitehead, M., Diderichsen, F., Olesen, H. V., Pressler, T., Smyth, R. L., & Diggle, P. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200953 · Cited by 182
Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients
Taccetti, G., Campana, S., Festini, F., Mascherini, M., & Döring, G. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00009605 · Cited by 181
Self-citationWainwright, C. E., Vidmar, S., Armstrong, D. S., Byrnes, C. A., Carlin, J. B., Cheney, J., Cooper, P. J., Grimwood, K., Moodie, M., Robertson, C. F., et al. (2011) · JAMA · doi:10.1001/jama.2011.954 · Cited by 180
Primm, T. P., & Falkinham, J. O. (2014) · Reference Module in Biomedical Sciences · doi:10.1016/b978-0-12-801238-3.03009-9 · Cited by 178
Tunney, M. M., Klem, E. R., Fodor, A. A., Gilpin, D. F., Moriarty, T. F., McGrath, S. J., Muhlebach, M. S., Boucher, R. C., Cardwell, C., Doering, G., et al. (2011) · Thorax · doi:10.1136/thx.2010.137281 · Cited by 175
Self-citationOrdoñez, C. L., Henig, N. R., Mayer-Hamblett, N., Accurso, F. J., Burns, J. L., Chmiel, J. F., Daines, C. L., Gibson, R. L., McNamara, S., Retsch-Bogart, G. Z., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200306-731oc · Cited by 167
Stenotrophomonas maltophilia in Cystic Fibrosis: Serologic Response and Effect on Lung Disease
Waters, V., Yau, Y., Prasad, S., Lu, A., Atenafu, E., Crandall, I., Tom, S., Tullis, E., & Ratjen, F. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201009-1392oc · Cited by 167
Stutman, H. R., Lieberman, J. M., Nussbaum, E., & Marks, M. I. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.121930 · Cited by 166
Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: The EVOLVE trial
Konstan, M. W., Geller, D. E., Minić, P., Brockhaus, F., Zhang, J., & Angyalosi, G. (2011) · Pediatric Pulmonology · doi:10.1002/ppul.21356 · Cited by 166
Cantón, R., Cobos, N., de Gracia, J., Baquero, F., Honorato, J., Gärtner, S., Alvarez, A., Salcedo, A., Oliver, A., & Garcia-Quetglas, E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01217.x · Cited by 158
Rogers, G. B., Carroll, M. P., Serisier, D. J., Hockey, P., Jones, G., Kehagia, V., Connett, G. J., & Bruce, K. D. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.02282-05 · Cited by 150
Smith, A. L., Doershuk, C. F., Goldmann, D. A., Gore, E., Hilman, B. C., Marks, M. I., Moss, R. B., Ramsey, B. W., Redding, G. J., Rubio, T. T., et al. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70197-6 · Cited by 140
Lung Function from Infancy to the Preschool Years after Clinical Diagnosis of Cystic Fibrosis
Kozlowska, W., Bush, A., Wade, A. M., Aurora, P., Carr, S. B., Castle, R. A., Hoo, A., Lum, S., Price, J., Ranganathan, S., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1599oc · Cited by 140
Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial
Assael, B. M., Pressler, T., Bilton, D., Fayon, M. J., Fischer, R., Chiron, R., Larosa, M., Knoop, C., McElvaney, N. G., Lewis, S. A., et al. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.07.006 · Cited by 139
Geller, D. E., Flume, P. A., Staab, D., Fischer, R., Loutit, J., & Conrad, D. J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201008-1293oc · Cited by 132
Self-citationDetecting Stenotrophomonas maltophilia Does Not Reduce Survival of Patients with Cystic Fibrosis
Goss, C. H., Otto, K., Aitken, M. L., & Rubenfeld, G. D. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2109078 · Cited by 131
Inhaled antibiotics for long-term therapy in cystic fibrosis
RYAN, G. F., Singh, M., & Dwan, K. M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001021.pub2 · Cited by 130
McCormick, J., Mehta, G., Olesen, H. V., Viviani, L., Maçek, M., & Mehta, A. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62161-9 · Cited by 128
Patient-reported Outcomes in Cystic Fibrosis
Goss, C. H., & Quittner, A. L. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200703-039br · Cited by 128
Mycobacterial lung disease in cystic fibrosis: a prospective study
Fauroux, B., Delaisi, B., Clément, A., Saizou, C., Moissenet, D., Truffot-Pernot, C., Tournier, G., & Vu-Thien, H. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199704000-00004 · Cited by 122
Blainey, P. C., Milla, C. E., Cornfield, D. N., & Quake, S. R. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004458 · Cited by 122
Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients
Worlitzsch, D., Rintelen, C., Böhm, K., Wollschläger, B., Merkel, N., Borneff-Lipp, M., & Döring, G. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02659.x · Cited by 121
Self-citationAspergillus fumigatus colonization in cystic fibrosis: implications for lung function?
de Vrankrijker, A. M. M., van der Ent, C. K., van Berkhout, F. T., Stellato, R. K., Willems, R. J. L., Bonten, M. J. M., & Wolfs, T. F. W. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03429.x · Cited by 120
Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease
Döring, G., & Gulbins, E. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01271.x · Cited by 118
Self-citationImproving rate of decline of FEV1 in young adults with cystic fibrosis
Que, C. (2005) · Thorax · doi:10.1136/thx.2005.043372 · Cited by 118
Döring, G., Parameswaran, G. I., & Murphy, T. F. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00237.x · Cited by 116
Self-citationParkins, M. D., Rendall, J. C., & Elborn, J. S. (2011) · CHEST Journal · doi:10.1378/chest.11-0917 · Cited by 116
Self-citationTrapnell, B. C., McColley, S. A., Kissner, D. G., Rolfe, M. W., Rosen, J. M., McKevitt, M. T., Moorehead, L., Montgomery, A. B., & Geller, D. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0924oc · Cited by 115
Johansen, H. K., Aanæs, K., Pressler, T., Nielsen, K. G., Fisker, J., Skov, M., Høiby, N., & von Buchwald, C. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.04.011 · Cited by 110
Nontuberculous mycobacterial infection in young children with cystic fibrosis
Esther, C. R., Henry, M. M., Molina, P. L., & Leigh, M. W. (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20222 · Cited by 110
Schechter, M. S., McColley, S. A., Silva, S., Haselkorn, T., Konstan, M. W., & Wagener, J. S. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.04.059 · Cited by 107
Sawicki, G. S., Rasouliyan, L., McMullen, A. H., Wagener, J. S., McColley, S. A., Pasta, D. J., & Quittner, A. L. (2011) · Pediatric Pulmonology · doi:10.1002/ppul.21325 · Cited by 106
Pulmonary exacerbations in cystic fibrosis
Stenbit, A. E., & Flume, P. A. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32834b8c04 · Cited by 105
Self-citationOkusanya, Ó. O., Bhavnani, S. M., Hammel, J., Minic, P. B., Dupont, L., Forrest, A., Mulder, G.-J., Mackinson, C., Ambrose, P. G., & Gupta, R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00872-08 · Cited by 104
Taccetti, G., Bianchini, E., Cariani, L., Buzzetti, R., Costantini, D., Trevisan, F., Zavataro, L., & Campana, S. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200832 · Cited by 104
Proesmans, M., Vermeulen, F. L., Boulanger, L., Verhaegen, J., & Boeck, K. D. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.06.001 · Cited by 103
Prophylactic anti-staphylococcal antibiotics for cystic fibrosis
Smyth, A. R., & Walters, S. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001912 · Cited by 100
Adherence with tobramycin inhaled solution and health care utilization
Briesacher, B. A., Quittner, A. L., Saiman, L., Sacco, P., Fouayzi, H., & Quittell, L. M. (2011) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-11-5 · Cited by 95
Evaluating the “Leeds criteria” forPseudomonas aeruginosainfection in a cystic fibrosis centre
Proesmans, M., Balińska-Miśkiewicz, W., Dupont, L., Bossuyt, X., Verhaegen, J., Høiby, N., & Boeck, K. D. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00100805 · Cited by 94
Parenteral Aminoglycoside Therapy
Kumana, C. R., & Yuen, K. (1994) · Drugs · doi:10.2165/00003495-199447060-00004 · Cited by 93
Challenging and emerging pathogens in cystic fibrosis
de Vrankrijker, A. M. M., Wolfs, T. F. W., & van der Ent, C. K. (2010) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2010.07.003 · Cited by 92
Ulrich, M., Beer, I., Braitmaier, P., Dierkes, M., Kummer, F., Krismer, B., Schumacher, U., Graepler-Mainka, U., Riethmüller, J., Jensen, P. Ø., et al. (2010) · Thorax · doi:10.1136/thx.2010.137745 · Cited by 92
Self-citationInitial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis
Mayer-Hamblett, N., Kronmal, R. A., Gibson, R. L., Rosenfeld, M., Retsch‐Bogart, G. Z., Treggiari, M. M., Burns, J. L., Khan, U., Ramsey, B. W., & for the EPIC Investigators (2011) · Pediatric Pulmonology · doi:10.1002/ppul.21525 · Cited by 89
Rogers, G. B., Marsh, P., Stressmann, F. A., Allen, C. E., Daniels, T. V., Carroll, M. P., & Bruce, K. D. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03189.x · Cited by 88
Ciofu, O., Fussing, V., Bagge, N., Koch, C., & Høiby, N. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.3.391 · Cited by 88
Sawicki, G. S., Rasouliyan, L., Pasta, D. J., Regelmann, W. E., Wagener, J. S., Waltz, D. A., & Ren, C. L. (2008) · Pediatric Pulmonology · doi:10.1002/ppul.20914 · Cited by 87
Чучалин, А. Г., r, E. C., Gyurkovics, K. L. N., Trawinska-Bartnicka, M., Sands, D., Kapranov, N. I., Varoli, G., Preti, P. A. M., & Mazurek, H. (2007) · Pediatric Drugs · doi:10.2165/00148581-200709001-00004 · Cited by 86
Home intravenous antibiotic treatment of patients with cystic fibrosis
Strandvik, B., Hjelte, L., Malmborg, A.-S., et al. (1992) · Acta Paediatrica · doi:10.1111/j.1651-2227.1992.tb12239.x · Cited by 85
Are lower airway or throat cultures predictive of sinus bacteriology in cystic fibrosis?
Muhlebach, M. S., Miller, M. B., Moore, C. G., Wedd, J. P., Drake, A. F., & Leigh, M. W. (2006) · Pediatric Pulmonology · doi:10.1002/ppul.20396 · Cited by 85
Kendig and Chernick’s Disorders of the Respiratory Tract in Children
Kendig, E. L., Chernick, V., & Wilmott, R. W. (2012) · Cited by 83
Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection
Moskowitz, S. M., Emerson, J., McNamara, S., Shell, R. D., Orenstein, D. M., Rosenbluth, D., Katz, M. F., Ahrens, R. C., Hornick, D. B., Joseph, P. M., et al. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21350 · Cited by 81
Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls
Bambha, K. M., & Kim, W. R. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200406000-00003 · Cited by 77
Cost of care and clinical condition in paediatric cystic fibrosis patients
Baumann, U., Stocklossa, C., Greiner, W., von der Schulenburg, J. G., & von der Hardt, H. (2003) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(03)00024-9 · Cited by 75
Exacerbations in cystic fibrosis: 3 {middle dot} Management
Smyth, A. R., & Elborn, J. S. (2007) · Thorax · doi:10.1136/thx.2006.060905 · Cited by 75
Self-citationSinonasal persistence of Pseudomonas aeruginosa after lung transplantation
Mainz, J. G., Hentschel, J., Schien, C., Cramer, N., Pfister, W., Beck, J. F., & Tümmler, B. (2011) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2011.10.009 · Cited by 74
Ratjen, F. A., Walter, H. J., Haug, M., Meisner, C., Grasemann, H., & Döring, G. (2007) · Pediatric Pulmonology · doi:10.1002/ppul.20562 · Cited by 72
Self-citationPressler, T., Karpati, F., Granström, M., Knudsen, P. K., Lindblad, A., Hjelte, L., Olesen, H. V., Meyer, P., & Høiby, N. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.08.002 · Cited by 70
Rosenfeld, M., Gibson, R., McNamara, S., Emerson, J., McCoy, K., Shell, R., Borowitz, D., Konstan, M., Retsch-Bogart, G., Wilmott, R., et al. (2001) · Jornal de Pediatria · doi:10.1067/mpd.2001.117785 · Cited by 69
Home intravenous antibiotic treatment in cystic fibrosis.
Gilbert, J., Robinson, T., & Littlewood, J. M. (1988) · Archives of Disease in Childhood · doi:10.1136/adc.63.5.512 · Cited by 67
Cystic fibrosis mortality trends in France
Bellis, G., Cazes, M.-H., Parant, A., et al. (2006) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2006.07.001 · Cited by 66
Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis
Treggiari, M. M., Rosenfeld, M., Retsch‐Bogart, G. Z., Gibson, R. L., & Ramsey, B. W. (2007) · Pediatric Pulmonology · doi:10.1002/ppul.20665 · Cited by 65
Recurrent exacerbations affect FEV1 decline in adult patients with cystic fibrosis
Amadori, A., Antonelli, A., Balteri, I., Schreiber, A., Bugiani, M., & De Rose, V. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.09.024 · Cited by 64
Foweraker, J. E., Laughton, C. R., Brown, D. F. J., & Bilton, D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00269-09 · Cited by 63
Shifting patterns of inhaled antibiotic use in cystic fibrosis
Moskowitz, S. M., Silva, S. J., Mayer-Hamblett, N., Pasta, D. J., Mink, D. R., Mabie, J. A., Konstan, M. W., & Wagener, J. S. (2008) · Pediatric Pulmonology · doi:10.1002/ppul.20873 · Cited by 61
Karpati, F., Malmborg, A. S., Alfredsson, H., Hjelte, L., & Strandvik, B. (1994) · Infection · doi:10.1007/bf01739911 · Cited by 60
VanDevanter, D. R., O’Riordan, M. A., Blumer, J. L., & Konstan, M. W. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-137 · Cited by 59
Vanderhelst, E., Meırleır, L. D., Verbanck, S. A. B., Piérard, D., Vincken, W., & Malfroot, A. (2011) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2011.08.006 · Cited by 58
Tramper‐Stranders, G. A., van der Ent, C. K., Molin, S., Yang, L., Hansen, S. K., Rau, M. H., Ciofu, O., Johansen, H. K., & Wolfs, T. F. W. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03627.x · Cited by 47
The Role of Azithromycin in Patients with Cystic Fibrosis
Yousef, A. A., & Jaffé, A. (2010) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2009.12.003 · Cited by 44
Measuring health-related quality of life in clinical trials in cystic fibrosis
Abbott, J., Hart, A., Havermans, T., Matossian, A., Goldbeck, L., Barreto, C., Brucefors, A. B., Besier, T., Catastini, P., Lupi, F., et al. (2011) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(11)60013-1 · Cited by 42
Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial
Anstead, M., Heltshe, S. L., Khan, U., et al. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.08.001 · Cited by 41
Noah, T. L., Ivins, S. S., Abode, K. A., et al. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21176 · Cited by 39
Knudsen, P. K., Olesen, H. V., Høiby, N., Johannesson, M., Karpati, F., Lærum, B. N., Meyer, P., Pressler, T., & Lindblad, A. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.11.001 · Cited by 39
Rogers, G. B., Hoffman, L. R., & Döring, G. (2011) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2011.06.014 · Cited by 33
Self-citationLeLorier, J., Perreault, S., Birnbaum, H., et al. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)87985-0 · Cited by 28
Benchmarking to improve the quality of cystic fibrosis care
Schechter, M. S. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328358d533 · Cited by 27
High Pseudomonas aeruginosa acquisition rate in CF
van Ewijk, B. E. (2006) · Thorax · doi:10.1136/thx.2006.062372 · Cited by 22
Economic evaluation of Tobramycin nebuliser solution in cystic fibrosis
Iles, R. W., Legh-Smith, J., Drummond, M., Prevost, A. T., & Vowler, S. L. (2003) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(03)00064-x · Cited by 20
Fleet, J. E., Guha, K., Piper, S., BANYA, W. A. S., Bilton, D., & Hodson, M. E. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.05.010 · Cited by 17
Integrating Patient-Reported Outcomes Into Research and Clinical Practice
Quittner, A. L., Nicolais, C. J., & Saez-Flores, E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44887-1.00013-4 · Cited by 15
Dupont, L., Clancy, J. P., Minic, P. B., et al. (2010) · doi:10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1836 · Cited by 12
Wharf, C., & London, E. (2012) · Cited by 9
Cited by
Elborn, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00576-6 · Cited by 1,805
Self-citationECFS best practice guidelines: the 2018 revision
Castellani, C., Duff, A. J. A., Bell, S. C., Heijerman, H. G. M., Munck, A., Ratjen, F., Sermet-Gaudelus, I., Southern, K. W., Barben, J., Flume, P. A., et al. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.02.006 · Cited by 765
Self-citationESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014
Høiby, N., Bjarnsholt, T., Moser, C., Bassi, G. L., Coenye, T., Donelli, G., Hall-Stoodley, L., Holá, V., Imbert, C., Kirketerp-Møller, K., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.10.024 · Cited by 726
European cystic fibrosis society standards of care: best practice guidelines
Smyth, A. R., Bell, S. C., Bojcin, S., Bryon, M., Duff, A., Flume, P., Kashirskaya, N., Munck, A., Ratjen, F., Schwarzenberg, S. J., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.03.010 · Cited by 582
Self-citationPhysicochemical properties of mucus and their impact on transmucosal drug delivery
Leal, J., Smyth, H. D. C., & Ghosh, D. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.018 · Cited by 560
Metadata
- Authors
- Döring, G., Flume, P., Heijerman, H., & Elborn, J. S.
- Venue
- Journal of Cystic Fibrosis
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 11
- Issue
- 6
- Pages
- 461-479
- ISSN
- 1569-1993 (ISSN-L)
- OpenAlex
- W2060894544
- Cited by
- 474
- References
- 157
- FWCI
- 30.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.